[1] Duygu O, David B, Paoco CC, et al. Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis[J] . Curr Diab Rep, 2011,11(3):193-202. [2] Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogesis[J] .Free Radic Bio Med, 1996,20(5):707-727. [3] 陈奇,主编. 中药药理研究方法学[M]. 2版.北京:人民卫生出版社,1994:925. [4] 宋立群,周延萌,马小茜,等. 中药对血管内皮细胞保护作用的研究进展[J] .医药导报,2009,6(28):735-736. [5] Rubanyi GM. The role of endothelium in cardiovascular homestasis and disease[J]. J Cardiovasc Pharmacol, 1993,22(suppl):1-14. [6] 陈艾东,李娟,谢海棠. 内皮素心血管效应的研究进展[J].中国临床药理学与治疗学,2011,16(8):937-944. [7] 胡哲一,王秋娟,丁选胜.动脉粥样硬化过程中内皮细胞功能障碍及药物治疗[J].中国临床药理学与治疗学,2006,11(5):481-484. [8] Kawabe J, Yuhki K, Okada M, et al. Prostaglandin I2 promotes recruitment of endothelial progenitor cells and limits vascular remodeling[J].Arterioscler Thromb Vasc Biol,2010,30(3):464-470. [9] Emer M Smyth. Thromboxane and the thromboxane receptor in cardiovascular disease[J].Clin Lioidol,2010,5(2):209-219. [10] Wang JA, Zhen EZ, Guo ZZ, et al. Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: protective effect of antioxidants[J].Free Radic Biol Med, 1989,7(3):243-249. [11] 张启春,卞慧敏,喻丽珍,等. 六味地黄方含药血清对氧化低密度脂蛋白损伤血管内皮细胞的保护作用[J].中国实验方剂学杂志,2007,13(7):31-34. [12] 吴艳, 李育, 张启春, 等. 六味地黄方对去卵巢雌性大鼠动脉粥样硬化模型的影响[J].中成药,2012,34(3):553-556. |